Fei Mo
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Immunology top 10%
- Immune cells in cancer
- Immune Cell Function and Interaction
- interferon and immune responses
- Immunotherapy and Immune Responses
Papers in
-
- Immune Response and Inflammation 4
- Immune cells in cancer 3
- interferon and immune responses 2
- Co-authors
- Xiawei Wei (8 shared papers)Xuelei Ma (7 shared papers)Yuquan Wei (8 shared papers)Xia Yuan (3 shared papers)Weiqi Hong (3 shared papers)Ziqi Zhang (3 shared papers)Jing Zhang (1 shared paper)Wei Du (1 shared paper)
- Journals
- Frontiers in Cell and Developmental Biology (3 papers)Nature Cell Biology (2 papers)Molecular Cancer (1 paper)Current Gene Therapy (1 paper)Medicine (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Fei Mo
32 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 115
- Geriatrics and Gerontology 58
- Immunology 356
- Oncology 244
- Physiology 32
- Reproductive Medicine 54
Countries citing papers authored by Fei Mo
This map shows the geographic impact of Fei Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Mo more than expected).
Fields of papers citing papers by Fei Mo
This network shows the impact of papers produced by Fei Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Mo. The network helps show where Fei Mo may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 199 | |
| 2 | 2021 | 155 | |
| 3 | 2020 | 138 | |
| 4 | 2020 | 77 | |
| 5 | 2020 | 74 | |
| 6 | 2020 | 56 | |
| 7 | 2020 | 54 | |
| 8 | 2017 | 45 | |
| 9 | 2023 | 43 | |
| 10 | 2020 | 37 | |
| 11 | 2024 | 24 | |
| 12 | 2020 | 19 | |
| 13 | 2023 | 18 | |
| 14 | 2021 | 16 | |
| 15 | 2019 | 16 | |
| 16 | 2022 | 14 | |
| 17 | 2021 | 10 | |
| 18 | 2023 | 10 | |
| 19 | 2019 | 10 | |
| 20 | 2017 | 10 |
About Fei Mo
Fei Mo is a scholar working on Immunology, Molecular Biology, Oncology, Pollution and Neurology, having authored 34 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immune Response and Inflammation (4 papers), Immune cells in cancer (3 papers), Microplastics and Plastic Pollution (3 papers), Chemokine receptors and signaling (3 papers), interferon and immune responses (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Heavy Metal Exposure and Toxicity (2 papers) and Antimicrobial Peptides and Activities (2 papers). The work is most often cited by research in Geriatrics and Gerontology (58 citations), Immunology (356 citations), Oncology (244 citations), Physiology (32 citations) and Reproductive Medicine (54 citations). Fei Mo has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xiawei Wei, Xuelei Ma, Yuquan Wei, Xia Yuan, Weiqi Hong, Ziqi Zhang, Jing Zhang, Wei Du, Dan Li and Mengyuan Huang. Their work appears in journals such as Frontiers in Cell and Developmental Biology, Nature Cell Biology, Molecular Cancer, Current Gene Therapy and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.